Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet activation during injury or inflammation triggers the release of numerous growth factors from storage granules within platelets—including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and interleukin-1β (IL-1β)[1]. These factors orchestrate tissue repair by stimulating cell proliferation, migration, angiogenesis, and extracellular matrix remodeling. The precise kinetics and composition of released factors depend on the method of platelet activation and the type of platelet preparation (e.g., platelet-rich plasma, platelet-rich fibrin)[1][9]. Aberrant or dysregulated release of these factors can influence disease pathology such as fibrosis, atherosclerosis, and cancer progression[2][9]. This is not an individual molecular target but instead a multifactorial biological process. For structured molecular targeting, refer to specific molecules such as platelet-derived growth factor (PDGF) or its receptors (e.g., PDGF receptor alpha or beta)[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth factor release from platelets.